FDA daily for Saturday, August 1, 2026
In this issue: 1 shortage update, 1 approval and 9 label changes.
Drug shortages
FDA date:FDA updated 1 shortage entry on Fri, Jul 31: 1 resolved.
- Triamcinolone Acetonide Injection
Harrow Eye, LLC
Drug and biologic approvals
FDA date:On Sat, Jul 25 FDA approved no new applications and 1 supplement to existing ones.
- DYNA-HEX 2
XTTRIUM · CHLORHEXIDINE GLUCONATE
Label updates
FDA date:9 drug labels took effect on Sat, Jul 18. Below: those, and labels carrying a boxed warning.
- Levofloxacin
LEVOFLOXACIN · HAWAII REPACK, INC. · ORAL
- Hydrocodone Bitartrate and Acetaminophen
HYDROCODONE BITARTRATE AND ACETAMINOPHEN · Eywa Pharma Inc · ORAL
- Clindamycin hydrochloride
CLINDAMYCIN HYDROCHLORIDE · HAWAII REPACK, INC. · ORAL
FDA did not answer for Device recalls, Clearances, Food and supplement recalls, Drug recalls while this issue was written; those sections will fill in on a later visit.
How the FDA daily is written
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.
Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.
